Streptokinase - A clinically useful thrombolytic agent

Biotechnology Advances

Volumn 22, Issue 4, 2004, Pages 287-307

  Banerjee, Anirban ^a   Chisti, Yusuf ^b   Banerjee, U C ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

Fibrinolysis; Staphylokinase; Streptokinase; Thrombolytic agents; Tissue type plasminogen activator; Urokinase

Indexed keywords

BLOOD; COST EFFECTIVENESS; ENZYME KINETICS; PATHOLOGY; PROTEINS; TISSUE;

HEMOSTASIS;

BIOTECHNOLOGY;

BIOTECHNOLOGY; BLOOD; HEMATOLOGY;

EID: 0345801344     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2003.09.004     Document Type: Article

References (171)

1. Adams D.S., Griffin L.A., Nachajko W.R., Reddy V.B., Wei C.M. A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor. J. Biol. Chem. 266:1991;8476-8482.
2. Andreas E.M. Affinity chromatographic purification of streptokinase with monoclonal antibodies. Allerg. Immunol. (Leipzig). 36:1990;277-285.
3. Avilan L., Yarzabal A., Jurgensen C., Bastidas M., Cruz J., Puig J. Cloning, expression and purification of recombinant streptokinase: partial characterization of the protein expressed in Escherichia coli. Braz. J. Med. Biol. Res. 30:1997;1427-1430.
4. Azuaga A.I., Woodruff N.D., Conejero-Lara F., Cox V.F., Smith R.A.G., Dobson C.M. Expression and characterization of the intact N-terminal domain of streptokinase. Protein Sci. 8:1999;443-446.
5. Azuaga A.I., Dobson C.M., Mateo P.L., Conejero-Lara F. Unfolding and aggregation during the thermal denaturation of streptokinase. Eur. J. Biochem. 269:2002;4121-4133.
6. Baewald G, Mayer G, Heikel R, Volzke KD, Roehlig R, Decker KL, et al. Fermentative production of Streptococcus metabolites, especially streptokinase. German patent DD 111096 (1975).
7. Bajaj A.P., Castellino F.J. Activation of human plasminogen by equimolar levels of streptokinase. J. Biol. Chem. 252:1977;492-498.
8. Barlow G.H. Urinary and kidney cell plasminogen activator (urokinase). Methods Enzymol. 45:1976;239-244.
9. Bärwald G., Jahn G., Volzke K.D. Microbiological isolation of a protease with fibrinolytic effect from Aspergillus ochraceus. Folia Haematol. 101:1974;83-93.
10. Beldarrain A., Lopez-Lacomba J.L., Kutyshenko V.P., Serrano R., Cortijo M. Multidomain structure of a recombinant streptokinase. A differential scanning calorimetry study. J. Protein Chem. 20:2001;9-17.
11. Bernheimer A.W., Gillman W., Hottle G.A., Pappenheimer A.M. An improved medium for the cultivation of hemolytic streptococcus. J. Bacteriol. 43:1942;495-498.
12. Bick R.L. Clinical relevance of anti-thrombin-III. Semin. Thromb. Hemost. 8:1982;276-287.
13. Boxrud P.D., Bock P.E. Streptokinase binds preferentially to the extended conformation of plasminogen through lysine binding site and catalytic domain interactions. Biochemistry (U.S.). 39:2000;13974-13981.
14. Boxrud P.D., Verhamme I.M.A., Fay W.P., Bock P.E. Streptokinase triggers conformational activation of plasminogen through specific interactions of the amino-terminal sequence and stabilizes the active zymogen conformation. J. Biol. Chem. 276:2001;26084-26089.
15. Brockway W.J., Castellino F.J. A characterization of native streptokinase and altered streptokinase isolated from a human plasminogen activator complex. Biochemistry. 13:1974;2063-2070.
16. Camiolo S.M., Thorsen S., Astrup T. Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc. Soc. Exp. Biol. Med. 138:1971;277-280.
17. Castellino F.J. Recent advances in the chemistry of the fibrinolytic system. Chem. Rev. 81:1981;431-446.
18. Castellino F.J. Biochemistry of human-plasminogen. Semin. Thromb. Hemost. 10:1984;18-23.
19. Castellino F.J., Sodetz J.M., Brockway W.J., Siefring G.E. Streptokinase. Methods Enzymol. 45:1976;244-257.
20. Chisti Y. Strategies in downstream processing. Subramanian G. Bioseparation and Bioprocessing: A Handbook. vol. 2:1998;3-30 Wiley-VCH, New York.
21. Chisti Y. Biosafety. Subramanian G. Bioseparation and Bioprocessing: A Handbook. vol. 2:1998;379-415 Wiley-VCH, New York.
22. Christensen L.R. Streptococcal fibrinolysis: a proteolytic reaction due to serum enzyme activated by streptococcal fibrinolysin. J. Gen. Physiol. 28:1945;363-383.
23. Christensen L.R. Methods for measuring the activity of components of the Streptococcal fibrinolytic system and Streptococcal desoxyribonuclease. J. Clin. Invest. 28:1949;163-172.
24. Coffey J.A., Jennings K.R., Dalton H. New antigenic regions of streptokinase are identified by affinity-directed mass spectrometry. Eur. J. Biochem. 268:2001;5215-5221.
25. Collen D. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Ann. Intern. Med. 112:1990;529-538.
26. Collen D., Stump D.C., Gold H.K. Thrombolytic therapy. Annu. Rev. Med. 39:1988;405-423.
27. Collen D., DeCock F., Vanlinthout I., Declerck P.J., Lijnen H.R., Stassen J.M. Comparative thrombolytic and immunogenic properties of staphylokinase and streptokinase. Fibrinolysis. 6:1992;232-242.
28. Conejero-Lara K., Parrado J., Azuaga A.I., Smith R.A.G., Ponting C.P., Dobson C.M. Thermal stability of the three domains of streptokinase studied by circular dichroism and nuclear magnetic resonance. Protein Sci. 5:1996;2583-2591.
29. Davie E.W., Neurath H. Identification of the peptide split from trypsinogen during autocatalytic activation. Biochim. Biophys. Acta. 11:1953;442.
30. Davies H.C., Karush F., Rudd J.H. Effect of amino acids on steady-state growth of a group A hemolytic streptococcus. J. Bacteriol. 89:1965;421-427.
31. Derechin M. Hydrolysis of some casein fractions with lasmin. Biochem. J. 82:1962;42-47.
32. De Renzo E.C., Siiteri P.K., Hutchings B.L., Bell P.H. Preparation and certain properties of highly purified streptokinase. J. Biol. Chem. 242:1967;533-542.
33. Einarsson M., Skoog B., Forsberg B., Einarsson R. Characterization of highly purified native streptokinase and altered streptokinase after alkaline treatment. Biochim. Biophys. Acta. 568:1979;19-29.
34. Eisenberg P.R., Jaffe A.S., Stump D.C., Collen D., Bovill E.G. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. Circulation. 82:1990;1159-1168.
35. Ellis R.P., Armstrong C.H. Production of capsules, streptokinase, and strepodonase by Streptococcus group E. Am. J. Vet. Res. 32:1971;349-356.
36. Estrada M.P., Hernandez L., Perez A., Rodriguez P., Serrano R., Rubier A.R.et al. High-level expression of streptokinase in Escherichia coli. Biotechnology. 10:1992;1138-1142.
37. Fabian H., Naumann D., Misselwitz R., Ristau O., Gerlach D., Welfle H. Secondary structure of streptokinase in aqueous solution - a Fourier transform infrared spectroscopic study. Biochemistry. 31:1992;6532-6538.
38. Fay W., Bokka L. Structure-function analyses of recombinant streptokinase. Blood. 86:1995;1131.
39. Fay W.P., Bokka L.V. Functional analysis of the amino- and carboxyl-termini of streptokinase. Thromb. Hemost. 79:1998;985-991.
40. Feldman LJ. Streptokinase manufacture. In German. German patent DE 2354019 (1974).
41. Francis C.W., Marder V.J. Fibrinolytic therapy for venous thrombosis. Prog. Cardiovasc. Dis. 34(3):1991;193-204.
42. Galler LI. Streptokinase derivatives with high affinity for activated platelets and methods of their production and use in thrombolytic therapy. US patent 6087332 (2000).
43. Gase K., Ellinger T., Malke H. Complex transcriptional control of the streptokinase gene of Streptococcus equisimilis H46A. Mol. Gen. Genet. 247:1995;749-758.
44. Gillis J.C., Goa K.L. Streptokinase-A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction. PharmacoEconomics. 10(3):1996;281-310.
45. Grafe S., Ellinger T., Malke H. Structural dissection and functional analysis of the complex promoter of the streptokinase gene from Streptococcus equisimilis H46A. Med. Microbiol. Immun. 185:1996;11-17.
46. Hagenson M.J., Holden K.A., Parker K.A., Wood P.J., Cruze J.A., Fuke M. et al. Expression of streptokinase in Pichia pastoris yeast. Enzyme Microb. Technol. 11:1989;650-656.
47. Hernandez-Pinzon I., Millan F., Bautista J. Streptokinase recovery by cross-flow microfiltration: study of enzyme denaturation. Biosci. Biotechnol. Biochem. 61:1997;1240-1243.
48. Holmstrom B. Streptokinase assay on large agar diffusion plates. Acta Chem. Scand. 19:1965;1549-1554.
49. Huang T.T., Malke H., Ferretti J.J. Heterogeneity of the streptokinase gene in group A Streptococci. Infect. Immun. 57:1989;502-506.
50. Hummel B.C.W., Schor J.M., Buck F.F., Boggiano E., DeRenzo E.C. Quantitative enzymic assay of human plasminogen and plasmin with azocasein as substrate. Anal. Biochem. 11:1965;532-547.
51. Hyun H.H., Lee Y.B., Song K.H., Jeon J.Y., Lee H.H. Strain improvement for enhanced production of streptokinase and streptodornase in Streptococcus sp. J. Microbiol. Biotechnol. 7:1997;101-106.
52. Jackson K.W., Tang J. Complete amino acid sequence of streptokinase and its homology with serine proteases. Biochemistry. 21:1982;6620-6625.
53. Jennings K. Antibodies to streptokinase - once is enough. BMJ. 312:1996;393-394.
54. Johnsen L.B., Poulsen K., Kilian M., Petersen T.E. Purification and cloning of a streptokinase from Streptococcus uberis. Infect. Immun. 67:1999;1072-1078.
55. Johnsen L.B., Rasmussen L.K., Petersen T.E., Etzerodt M., Fedosov S.N. Kinetic and structural characterization of a two-domain streptokinase: dissection of domain functionality. Biochemistry (U.S.). 39:2000;6440-6448.
56. Kazmi K.A., Iqbal M.P., Rahbar A., Mehboobali N. Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients. Int. J. Cardiol. 82(3):2002;247-251.
57. Kim I.C., Kim J.S., Lee S.H., Byun S.M. C-terminal peptide of streptokinase, Met369-Pro373, is important in plasminogen activation. Biotechnol. Mol. Biol. Int. 40:1996;939-945.
58. Kim D.M., Lee S.J., Kim I.C., Kim S.T., Byun S.M. Asp41-His48 region of streptokinase is important in binding to a substrate plasminogen. Thromb. Res. 99:2000;93-98.
59. Kim D.M., Lee S.J., Yoon S.K., Byun S.M. Specificity role of the streptokinase C-terminal domain in plasminogen activation. Biochem. Biophys. Res. Commun. 290:2002;585-588.
60. Kline D.L., Fishman J.B. A simplified procedure for the isolation of purified human plasmin. Proc. Intern. Symp., Anticoagulants Fibrinolysins, Toronto. 1961;360-364.
61. Kline D.L., Fishman J.B. Improved procedure for the isolation of human plasminogen. J. Biol. Chem. 236:1961;3232-3234.
62. Ko J.H., Park D.K., Kim I.C., Lee S.H., Byun S.M. High-level expression and secretion of streptokinase in Escherichia coli. Biotechnol. Lett. 17:1995;1019-1024.
63. Koide A., Suzuki S., Kobayashi S. Preparation of polyethylene glycol-modified streptokinase with disappearance of binding ability towards antiserum and retention of activity. FEBS Lett. 143:1982;73-76.
64. Kulisek E.S., Holm S.E., Johnston K.H. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using a para-nitroanilide synthetic peptide substrate. Med. Anal. Biochem. 177:1989;78-84.
65. Lack C.H. Staphylokinase: an activator of plasma protease. Nature. 161:1948;559-560.
66. Lancefield R.C. A serological differentiation of human and other groups of hemolytic Streptococci. J. Exp. Med. 57:1933;571-595.
67. Lee H.S. How safe is the readministration of streptokinase. Drug Saf. 13:1995;76-80.
68. Lee S.H., Kim I.C., Bae K.H., Byun S.M. Enhanced production and secretion of streptokinase into extracellular medium in Escherichia coli by removal of 13 N-terminal amino acids. Biotechnol. Lett. 19:1997;151-154.
69. Lee S.H., Jeong S.T., Kim I.C., Byun S.M. Identification of the functional importance of valine-19 residue in streptokinase by N-terminal deletion and site directed mutagenesis. Biochem. Mol. Biol. Int. 41:1997;199-207.
70. Leonardi M.S., Gazzara D., Fava C., Foca A., Mastroeni P. Enzyme-linked immunosorbent assay (ELISA) for streptokinase antibodies. Diagn. Immunol. 1:1983;64-67.
71. Lijnen H.R., Vanhoef B., DeCock F., Okada K., Ueshima S., Matsuo O.et al. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J. Biol. Chem. 266:1991;11826-11832.
72. Lijnen H.R., Stassen J.M., Vanlinthout I., Fukao H., Okada K., Matsuo O.et al. Comparative fibrinolytic properties of staphylokinase and streptokinase in animal models of venous thrombosis. Thromb. Hemost. 66:1991;468-473.
73. Liu L., Houng A., Tsai J., Chowdhry S., Sazonova I., Reed G.L. The fibronectin motif in the NH2-terminus of streptokinase plays a critical role in fibrin-independent plasminogen activation. Circulation. 100(Suppl. S):1999;1.
74. Malke H. Polymorphism of the streptokinase gene - implications for the pathogenesis of poststreptococcal lomerulonephritis. Zentralbl. Bakteriol. 278:1993;246-257.
75. Malke H., Ferretti J.J. Streptokinase: cloning, expression and excretion by Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 81:1984;3557-3561.
76. Malke H., Gerlach D., Kohler W., Ferretti J.J. Expression of a streptokinase gene from Streptococcus equisimilis in Streptococcus sanguis. Mol. Gen. Genet. 196:1984;360-363.
77. Malke H., Roe B., Ferretti J. Nucleotide sequence of the streptokinase gene from Streptococcus equisimilis H46A. Gene. 34:1985;357-362.
78. Malke H., Steiner K., Gase K., Frank C. Expression and regulation of the streptokinase gene. Methods. 21:2000;111-124.
79. Marder V.J. Recombinant streptokinase - opportunity for an improved agent. Blood Coagul. Fibrinolysis. 4:1993;1039-1040.
80. Marder V.J., Francis C.W., Norry E.C. Dose-ranging study of acylated streptokinase-plasminogen complex (BRL-26921). Thromb. Hemost. 50:1983;321.
81. Markus G., Evers J.L., Hobika G.H. Activator activities of the transient forms of the human plasminogen.streptokinase complex during its proteolytic conversion to the stable activator complex. J. Biol. Chem. 251:1976;6495-6504.
82. Marsh N.A., Gaffney P.J. The rapid fibrin plate - a method for plasminogen activator assay. Thromb. Hemost. 38:1977;545-551.
83. Matsuo O., Okada K., Fukao H., Tomioka Y., Ueshima S., Watanuki M.et al. Thrombolytic properties of staphylokinase. Blood. 76:1990;925-929.
84. McCoy H.E., Broder C.C., Lottenberg R. Streptokinases produced by pathogenic group C Streptococci demonstrate species-specific plasminogen activation. J. Infect. Dis. 164:1991;515-521.
85. Medved L.V., Solovjov D.A., Ingham K.C. Domain structure, stability and interactions in streptokinase. Eur. J. Biochem. 239:1996;333-339.
86. Misselwitz R., Kraft R., Kostka S., Fabian H., Welfle K., Pfeil W.et al. Limited proteolysis of streptokinase and properties of some fragments. Int. J. Biol. Macromol. 14:1992;107-116.
87. Mucklow J.C. Thrombolytic treatment - streptokinase is more economical than Alteplase. BMJ. 311:1995;1506.
88. Muller J., Malke H. Duplication of the streptokinase gene in the chromosome of Streptococcus equisimilis H46A. FEMS Microbiol. Lett. 72:1990;75-78.
89. Muller J., Reinert H., Malke H. Streptokinase mutations relieving Escherichia coli K-12 (PRLA4) of detriments caused by the wild-type skc gene. J. Bacteriol. 171:1989;2202-2208.
90. Mullertz S. Effect of carboxylic and amino acids on fibrinolysis produced by plasmin, plasminogen activator, and proteinases. Proc. Soc. Exp. Biol. Med. 85:1954;326-329.
91. Mullertz S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem. J. 61:1955;424-434.
92. Mundada L.V., Prorok M., DeFord M.E., Figuera M., Castellino F.J., Fay W.P. Structure-function analysis of the streptokinase amino terminus (residues 1-59). J. Biol. Chem. 278:2003;24421-24427.
93. Narciandi R.E., Morbe F.J., Riesenberg D. Maximizing the expression of recombinant kringle 1 (Streptokinase) synthesized in Escherichia coli. Influence of culture and induction conditions. Biotechnol. Lett. 18:1996;1261-1266.
94. Nemirovich-Danchenko MM, Alekseeva VN, Lebedeva VV, Shashkova NM, Feigel'man BI, Burovaya FI, Smirnova EM. Streptokinase. In Russian. USSR patent SU 1147749 (1985).
95. Nicolini F.A., Nichols W.W., Mehta J.L., Saldeen T.G.P., Schofield R., Ross M.et al. Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue plasminogen activator. J. Am. Coll. Cardiol. 20:1992;228-235.
96. Nihalani D., Sahni G. Streptokinase contains two independent plasminogen-binding sites. Biochem. Biophys. Res. Commun. 217:1995;1245-1254.
97. Nihalani D., Kumar R., Rajagopal K., Sahni G. Role of the amino-terminal region of streptokinase in the generation of a fully functional plasminogen activator complex probed with synthetic peptides. Protein Sci. 7:1998;637-648.
98. Ojalvo A.G., Pozo L., Labarta V., Torrens I. Prevalence of circulating antibodies against a streptokinase C-terminal peptide in normal blood donors. Biochem. Biophys. Res. Commun. 263:1999;454-459.
99. Ojalvo A.G., Torrens I., Seralena A., de la Fuente J. Recombinant streptokinase with reduced immunoreactivity. Thromb. Hemost. 817(Suppl. S):1999.
100. Okada K., Ueshima S., Fukao H., Matsuo O. Analysis of complex formation between plasmin(ogen) and staphylokinase or streptokinase. Arch. Biochem. Biophys. 393:2001;339-341.
101. Ozegowski J.H., Gerlach D., Kohler W. Influence of physical parameters on the production of streptococcal extracellular proteins in cultures with stabilized pH: 2. Temperature dependence of extracellular protein production. Zentralbl. Bakteriol., Microbiol. Hyg. 254:1983;361-369.
102. Paoletti R., Sherry S. Proceedings of the serono symposia. Thrombosis and Urokinase. vol. 9:1977;257 Academic Publisher, London.
103. ParhamiSeren B., Keel T., Reed G.L. Structural characterization of immunodominant regions of streptokinase recognized by murine monoclonal antibodies. Hybridoma. 15:1996;169-176.
104. ParhamiSeren B., Keel T., Reed G.L. Sequences of antigenic epitopes of streptokinase identified via random peptide libraries displayed on phage. J. Mol. Biol. 271:1997;333-341.
105. Parrado J., ConejeroLara F., Smith R.A.G., Marshall J.M., Ponting C.P., Dobson C.M. The domain organization of streptokinase: nuclear magnetic resonance, circular dichroism, and functional characterization of proteolytic fragments. Protein Sci. 5:1996;693-704.
106. Pautov V.D., Anufrieva E.V., Ananeva T.D., Saveleva N.V., Taratina T.M., Krakovyak M.G. Structural dynamic and functional properties of native and modified streptokinase. Mol. Biol. 24:1990;35-41.
107. Perez N., Urrutia E., Camino J., Orta D.R., Torres Y., Martinez Y.et al. Hydrophobic interaction chromatography applied to purification of recombinant streptokinase. Biotechnology. 10:1998;174-177.
108. Permin P.M. Properties of the fibrinokinase-fibrinolysin system. Nature. 160:1947;571-572.
109. Pratap J., Dikshit K.L. Effect of signal peptide changes on the extracellular processing of streptokinase from Escherichia coli: requirement for secondary structure at the cleavage junction. Mol. Gen. Genet. 258:1998;326-333.
110. Pratap J., Rajamohan G., Dikshit K.L. Characteristics of glycosylated streptokinase secreted from Pichia pastoris: enhanced resistance of SK to proteolysis by glycosylation. Appl. Microbiol. Biotechnol. 53:2000;469-475.
111. Pupo E., Baghbaderani B.A., Lugo V., Fernandez J., Paez R., Torrens I. Two streptokinase genes are expressed with different solubility in Escherichia coli W3110. Biotechnol. Lett. 21:1999;1119-1123.
112. Radek J.T., Castellino F.J. Conformational properties of streptokinase. J. Biol. Chem. 264:1989;9915-9922.
113. Rajagopalan S., Gonias S.L., Pizzo S.V. A non-antigenic covalent streptokinase polyethylene glycol complex with plasminogen activator function. J. Clin. Invest. 75:1985;413-419.
114. Reddy K., Nagendra N., Markus G. Esterase activities in the zymogen moiety of the streptokinase-plasminogen complex. J. Biol. Chem. 249:1974;4851-4857.
115. Reed G.L., Kussie P., Parhamiseren B. A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments. J. Immunol. 150:1993;4407-4415.
116. Reed G.L., Lin L.F., Parhami-Seren B., Kussie P. Identification of a plasminogen binding region in streptokinase that is necessary of the creation a functional streptokinase-plasminogen activator complex. Biochemistry. 34:1995;10266-10271.
117. Reed G.L., Liu L., Houng A.K., Matsueda L.H., Lizbeth H. Mechanisms of fibrin independent and fibrin dependent plasminogen activation by streptokinase. Circulation. 98:1998;199.
118. Regnault V., Helft G., Wahl D., Czitrom D., Vuillemenot A., Papouin G.et al. Anti streptokinase platelet-activating antibodies are common and heterogeneous. J. Thromb. Hemost. 1:2003;1055-1061.
119. Remmert L.M.F., Cohen P.P. Partial purification and properties of a proteolytic enzyme of human serum. J. Biol. Chem. 181:1949;431-448.
120. Roberts P.S. Measurement of the rate of plasmin action on synthetic substrates. J. Biol. Chem. 232:1958;285-291.
121. Roberts P.S. Esterase activities of human plasmin during purification and subsequent activation by streptokinase or glycerol. J. Biol. Chem. 235:1960;2262-2266.
122. Robinson B.R., Liu L., Houng A.K., Sazanova I.Y., Reed G.L. The streptokinase beta domain plays a critical role in activator complex formation and substrate docking. Circulation. 102:2000;490.
123. Rodriguez P., Hernandez L., Munoz E., Castro A., Fuente J.D.L., Herrera L. Purification of streptokinase by affinity-chromatography on immobilized acylated human plasminogen. BioTechniques. 12:1992;424.
124. Rodriguez P., Fuentes D., Munoz E., Rivero D., Orta D., Alburquerque S. et al. The streptokinase domain responsible for plasminogen binding. Fibrinolysis. 8:1994;276-285.
125. Rosenberger R.F., Elsden S.R. The yields of Streptococcus faecalis grown in continuous culture. J. Gen. Microbiol. 22:1960;726-739.
126. Rouf S.A., Moo-Young M., Chisti Y. Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnol. Adv. 14:1996;239-266.
127. Sako T. Overproduction of staphylokinase in Escherichia coli and its characterization. Eur. J. Biochem. 149:1985;557-563.
128. Saksela O. Radial caseinolysis in agarose: a simple method for detection of plasminogen activators in the presence of inhibitory substances and serum. Anal. Biochem. 111:1981;276-282.
129. Sane D.C., Little W.C. Is time running out on streptokinase? J. Am. Coll. Cardiol. 31:1998;780-782.
130. Sazonova I.Y., Houng A.K., Chowdhry S.A., Reed G.L. Mechanism of action of a novel Streptococcus uberis plasminogen activator (SUPA). Circulation. 102:2000;489.
131. Schlott B., Hartmann M., Guhrs K.H., Birchhirschfeid E., Pohl H.D., Vanderschueren S.et al. High yield production and purification of recombinant staphylokinase for thrombolytic therapy. Biotechnology. 12:1994;185-189.
132. Shemanova F., Postnikova T.M., Rostov G. Enzyme immunoassay of antistreptokinase. Klin. Lab. Diagn. 2:1995;26-29. [In Russian].
133. Sherry S., Marder V.J. Streptokinase and recombinant tissue plasminogen activator (rt-PA) are equally effective in treating acute myocardial infarction. Ann. Intern. Med. 114:1991;417-423.
134. Sherry S., Alkjaersig N., Fletcher A.P. Assay of urokinase preparations with the synthetic substrate acetyl-L-lysine methyl ester. J. Lab. Clin. Med. 64:1964;145-153.
135. Shi G.Y., Chang B.I., Chen S.M., Wu D.H., Wu H.L. Function of streptokinase fragments in plasminogen activation. Biochem. J. 304:1994;235-241.
136. Shi G.Y., Chang B.I., Su S.W., Young K.C., Wu D.H., Chang L.C.et al. Preparation of a novel streptokinase mutant with improved stability. Thromb. Hemost. 79:1998;992-997.
137. Siefring G.E., Castellino F.J. Interaction of streptokinase with plasminogen: isolation and characterization of a streptokinase degradation product. J. Biol. Chem. 251:1976;3913-3920.
138. α-CBZ-L-lysin p-nitrophenyl ester as substrate. Anal. Biochem. 65:1975;500-506.
139. Smith R.A.G., Dupe R.J., English P.D., Green J. Fibrinolysis with acyl-enzymes - a new approach to thrombolytic therapy. Nature. 290:1981;505-508.
140. Strassburger W., Wollmer A., Pitts J.E., Glover I.D., Tickle I.J., Blundell T.L.et al. Adaptation of plasminogen activator sequences to known protease structures. FEBS Lett. 157:1983;219-223.
141. Stuebner K., Boschke E., Wolfe K.-H., Langer J. Kinetic analysis and modeling of streptokinase fermentation. Acta Biotechnol. 11:1991;467-477.
142. Suh H., Kim K.H., Kim S.S., Han M.H. Culture conditions of Streptococcus sp. for streptokinase production. Sanop Misaengmul Hakhoechi. 12(3):1984;224-231.
143. Sundram V., Nanda J.S., Rajagopal K., Dhar J., Chaudhary A., Sahni G. Domain truncation studies reveal that the streptokinase-plasmin activator complex utilizes long range protein-protein interactions with macromolecular substrate to maximize catalytic turnover. J. Biol. Chem. 278:2003;30569-30577.
144. Taylor F.B., Botts J. Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen. Biochemistry. 7:1968;232-242.
145. Teuten A.J., Broadhurst R.W., Smith R.A.G., Dobson C.M. Characterization of structural and folding properties of streptokinase by NMR-spectroscopy. Biochem. J. 290:1993;313-319.
146. Tillett W.S., Garner R.L. Fibrinolytic activity of hemolytic streptococci. J. Exp. Med. 58:1933;485-502.
147. Tomar R.H. Streptokinase: preparation, comparison with streptococcal proteinase, and behavior as a trypsin substrate. Proc. Soc. Exp. Biol. Med. 127:1968;239-244.
148. Torrens I., Ojalvo A.G., Seralena A., de la Fuente J. Study of antigenic regions of streptokinase. Thromb. Hemost. 2288(Suppl. S):1999.
149. Torrens I., Ojalvo A.G., Seralena A., Hayes O., de la Fuente J. A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic. Immunol. Lett. 70:1999;213-218.
150. Troll W., Sherry S., Wachman J. The action of plasmin on synthetic substrates. J. Biol. Chem. 208:1954;85-93.
151. Wakeham N., Terzyan S., Zhai P.Z., Loy J.A., Tang J., Zhang X.C. Effects of deletion of streptokinase residues 48-59 on plasminogen activation. Protein Eng. 15:2002;753-761.
152. Wallen P. Purification of human plasminogen: I. The purification of a partially purified human plasminogen with a low spontaneous proteolytic activity. Ark. Kemi. 19:1962;451-468.
153. Wallen P. Purification of human plasminogen: II. Further purification of human plasminogen on cellulose ion exchangers and by means of gel filtration on Sephadex. Ark. Kemi. 19:1962;469-482.
154. Wang X., Lin X., Loy J.A., Tang J., Zhang X.C. Crystal structure of the catalytic domain of human plasmin complexed with streptokinase. Science. 281:1998;1662-1665.
155. Wang S.G., Reed G.L., Hedstrom L. The deletion of Ile1 changes the mechanism of streptokinase. FASEB J. 13:1999;A1535.
156. Wang S.G., Reed G.L., Hedstrom L. Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis. Biochemistry (U.S.). 38:1999;5232-5240.
157. Wang X.Q., Tang J., Hunter B., Zhang X.J.C. Crystal structure of streptokinase beta-domain. FEBS Lett. 459:1999;85-89.
158. Wasserman A.E., Ciminera J.L., Hayflick L., Verwey W.F. The determination of streptokinase. J. Lab. Clin. Med. 41:1953;812-818.
159. Welfle K., Pfeil W., Misselwitz R., Welfle H., Gerlach D. Conformational properties of streptokinase - differential scanning calorimetric investigations. Int. J. Biol. Macromol. 14:1992;19-22.
160. Werf F.V.D. Streptokinase...never again. Eur. Heart J. 20:1999;1215.
161. Westlund L.E., Andersson L.O. Variables influencing the clot lysis assay of streptokinase. Thromb. Res. 64:1991;713-721.
162. Wong S.L., Ye R.Q., Nathoo S. Engineering and production of streptokinase in Bacillus subtilis expression-secretion system. Appl. Environ. Microbiol. 60:1994;517-523.
163. Wu K.K., Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med. 47:1996;315-331.
164. Wu X.C., Ye R.Q., Duan Y.J., Wong S.-L. Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life. Appl. Environ. Microbiol. 64:1998;824-829.
165. Wu D.H., Shi G.Y., Chuang W.J., Hsu J.M., Young K.C., Chang C.W.et al. Coiled coil region of streptokinase gamma-domain is essential for plasminogen activation. J. Biol. Chem. 276:2001;15025-15033.
166. Yazdani S.S., Mukherjee K.J. Overexpression of streptokinase using a fed-batch strategy. Biotechnol. Lett. 20:1998;923-927.
167. Yazdani S.S., Mukherjee K.J. Continuous culture studies on the stability and expression of recombinant streptokinase in Escherichia coli. Bioprocess Biosyst. Eng. 24:2002;341-346.
168. Young K.C., Shi G.Y., Chang Y.F., Chang B.I., Chang L.C., Lai M.D.et al. Interaction of streptokinase and plasminogen - studied with truncated streptokinase peptides. J. Biol. Chem. 270:1995;29601-29606.
169. Young K.C., Shi G.Y., Wu D.H., Chang L.C., Chang B.I., Ou C.P.et al. Plasminogen activation by streptokinase via a unique mechanism. J. Biol. Chem. 273:1998;3110-3116.
170. Zhai P., Wakeham N., Loy J.A., Zhang X.C. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation. Biochemistry. 42:2003;114-120.
171. Zhang X.W., Sun T., Huang X.N., Liu X., Gu D.X., Tang Z.Q. Recombinant streptokinase production by fed-batch cultivation of Escherichia coli. Enzyme Microb. Technol. 24:1999;647-650.